Zhangzhou Pientzehuang Pharmaceutical | 600436 - Net Income


Zz Pientze Pharmaceu reported CNY687.04M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.16M 108K Sep/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Jiangsu Hengrui CNY 2.28B 322.38M Mar/2026
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Moderna USD -200M 625M Sep/2025
Revvity USD 98.36M 51.71M Dec/2025
Sh Fosun Pharma CNY 847.27M 25.94M Dec/2025
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Viatris USD -340.1M 211.9M Dec/2025
Wuxi Apptec CNY 7.08B 3.56B Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025
Zz Pientze Pharmaceu CNY 687.04M 244.51M Sep/2025